Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
April 15, 2021 16:39 ET
|
Adamis Pharmaceuticals Corporation
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the second quarter of 2021 Management to host webcast/conference call...
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business Update
April 13, 2021 16:03 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for respiratory...
Adamis Pharmaceuticals Provides an Update on ZIMHI™
April 12, 2021 07:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the status of the company’s New Drug Application (NDA) relating to its...
Deaths in Toronto Shelters at All Time High: CEO of Heart to Heart CPR Says That Shelter Staff is Taking the Wrong Course – A Claim Recently Supported by Newest Canadian 2020 Resuscitation Guidelines Released October 19, 2020
October 21, 2020 09:16 ET
|
Heart to Heart First Aid CPR Services Inc
TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Nick Rondinelli, CEO of Heart to Heart CPR, issued the following announcement: My name is Nick Rondinelli, CEO of Heart to Heart First Aid CPR Services...
Global Opioid Drugs Markets 2019-2020 & Forecast to 2028: Increased Number of Lawsuits Against the Manufacturers of Opioid Drugs Restraining Growth
September 29, 2020 06:24 ET
|
Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Opioid Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global opioids drug market to proliferate with...
Prescription Drug Monitoring Programs Don’t Work, according to Article in the Journal of American Physicians and Surgeons
June 13, 2019 12:25 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., June 13, 2019 (GLOBE NEWSWIRE) -- In response to the rising rate of drug overdose deaths, 49 states had a Prescription Drug Monitoring Program (PDMP) by 2014. By requiring physicians...
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001
October 09, 2018 08:00 ET
|
BioCorRx Inc
ANAHEIM, CA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- VDM-001 represents potential alternative to naloxone for overdose reversal; Potential to reduce cravings from substance use disorder via...
Heroin Detox Clinics Outlines The Opioid Epidemic And New Healthcare Guidelines
April 16, 2018 22:25 ET
|
Heroin Detox Clinics
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- HeroinDetoxClinics.com is responsible for providing helpful information for individuals looking for answers about drug addiction. The website breaks...
Physicians Enter a Minefield When Prescribing Opioids, according to the Journal of American Physicians and Surgeons
December 14, 2017 09:52 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 14, 2017 (GLOBE NEWSWIRE) -- As deaths from opioid overdoses soar, the government is targeting physicians for blame, writes Lawrence Huntoon, M.D., Ph.D., in the winter issue of...
AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
March 31, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...